Clinical Trial Update: Study Evaluating the Efficacy of Maintenance Olaparib and Cediranib or Olaparib Alone in Ovarian Cancer Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating maintenance olaparib with cediranib vs olaparib alone in ovarian cancer; status not specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Cediranib (Cediranib)
• Olaparib (Olaparib)

Snippet

Sponsor: University College, London | Conditions: Ovarian Cancer | Phase 3 | Status: UNKNOWN